Delaware Bill: HB 305

Bill Summary

Delaware HB305 establishes the Delaware Diabetes Wellness Pilot Program within the Department of Health and Social Services to study proactive diabetes care management. The program will enroll 400-500 volunteer Type 2 diabetes patients and partner with technology companies to provide personalized healthcare protocols including real-time blood glucose monitoring, dietary guidance, exercise recommendations, and lifestyle coaching. Participants will undergo baseline laboratory testing and be tracked against a control group, with data collected and analyzed by the Delaware Health Information Network every six months. The program is federally funded and will sunset three years after implementation unless extended or discontinued early based on results.

Why It Matters to MAHA

This bill exemplifies health freedom and patient autonomy by offering voluntary enrollment in an innovative, personalized diabetes management program rather than one-size-fits-all standard care. It prioritizes transparency through comprehensive data collection and regular public reporting of outcomes and cost savings, allowing patients and policymakers to evaluate effectiveness. The focus on preventive wellness and lifestyle modifications rather than pharmaceutical intervention aligns with MAHA's emphasis on addressing root causes of disease. The use of technology for real-time monitoring empowers patients with actionable health data about their own bodies. This pilot represents the kind of innovative treatment access and patient-centered medicine that MAHA champions.